Sciatica Therapy
Active substance: ARNICA MONTANA, CITRULLUS COLOCYNTHIS FRUIT PULP, PSEUDOGNAPHALIUM OBTUSIFOLIUM, HYPERICUM PERFORATUM, POTASSIUM IODIDE, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, TOXICODENDRON PUBESCENS LEAF
TABLET, ORALLY DISINTEGRATING · ARNICA MONTANA 6 [hp_X]/1, CITRULLUS COLOCYNTHIS FRUIT PULP 6 [hp_X]/1, PSEUDOGNAPHALIUM OBTUSIFOLIUM 6 [hp_X]/1, HYPERICUM PERFORATUM 6 [hp_X]/1, POTASSIUM IODIDE 6 [hp_X]/1, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE 6 [hp_X]/1, TOXICODENDRON PUBESCENS LEAF 6 [hp_X]/1
United StatesActive
Marketing holder: TRP Company
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- ARNICA MONTANA · 6 [hp_X]/1
- CITRULLUS COLOCYNTHIS FRUIT PULP · 6 [hp_X]/1
- PSEUDOGNAPHALIUM OBTUSIFOLIUM · 6 [hp_X]/1
- HYPERICUM PERFORATUM · 6 [hp_X]/1
- POTASSIUM IODIDE · 6 [hp_X]/1
- MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE · 6 [hp_X]/1
- TOXICODENDRON PUBESCENS LEAF · 6 [hp_X]/1
Registration
- Registration number
- 17312-021
- Registration status
- Active
- Dispensing
- Over the counter
- Route
- ORAL
Sources
- product · openFDA NDC · 17312-021 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 17312-021 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 17312-021 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 17312-021 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 17312-021 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 17312-021 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 17312-021 · Verified 2026-10-09 · open in source
- ingredients.5 · openFDA NDC · 17312-021 · Verified 2026-10-09 · open in source
- ingredients.6 · openFDA NDC · 17312-021 · Verified 2026-10-09 · open in source